[Webinar] U.S. Antitrust Law and Intellectual Property Law: Latest Issues and Trends Part 2
2023/11/1
China - Essential Knowledge on Revised "Anti-Espionage Law" Part 7
2023/11/8
Thursday, October 2023, 10 O'Melveny & Myers LLP / FRONTEO Co., Ltd. Co-hosted online seminar
After logging in, you can download the materials for the seminar to be held on September 2023, 10.
O’Melveny & Myers partners Rob Shaffer, Pete Herrick, and Steve McIntyre discuss hot topics and trends at the intersection of antitrust and intellectual property law.
The webinar will cover legal developments and litigation risks facing life sciences companies (including antitrust challenges to patent settlement agreements), antitrust policy under the Biden administration, and the U.S. Department of Justice and Federal Trade Commission’s recent enforcement actions in IP-intensive industries, among other subjects.
Only members can watch it.
Please refrain from registering at a law firm, in the same industry as our company, or with a free email address.
Thursday, October 2023, 10 O'Melveny & Myers LLP / FRONTEO Co., Ltd. Co-hosted online seminar
Subtitles are machine translated, not provided by a law firm
You can download materials for the seminar to be held on September 2023, 10 from the form below.
O’Melveny & Myers partners Rob Shaffer, Pete Herrick, and Steve McIntyre discuss hot topics and trends at the intersection of antitrust and intellectual property law.
The webinar will cover legal developments and litigation risks facing life sciences companies (including antitrust challenges to patent settlement agreements), antitrust policy under the Biden administration, and the U.S. Department of Justice and Federal Trade Commission’s recent enforcement actions in IP-intensive industries, among other subjects.
lecturer
O'Melveny & Myers LLP
Partner Rob Shaffer
Rob Shaffer is a nationally recognized first-chair IP trial lawyer with extensive experience handling complex patent litigation in the most important intellectual property matters. For more than 20 years, Rob has represented some of the world’s most innovative pharmaceutical and medical device companies in dozens of major cases, including Hatch-Waxman disputes, International Trade Commission (ITC) actions, and complex commercial arbitrations. He also represents clients before the Patent Trial and Appeal Board (PTAB) of the US Patent and Trademark Office (USPTO).
Rob advises clients through every step of patent litigation—from pre-trial counseling to leading trial teams, and through appeal. Along with his life sciences work, Rob also represents clients in other technologies, including consumer electronics, software, and gaming companies in patent matters.
Complementing his trial work, Rob advises clients on their patent strategies, including strategic portfolio management, licensing and transactional activities, and IP due diligence.
Rob has been recognized as a leading patent litigator by both the Legal 500 (2022) and IAM Patent 1000 (2022), which noted his “outstanding winning record” in pharmaceutical and biotechnology litigation.
O'Melveny & Myers LLP
Partner Pete Herrick
Peter Herrick has represented clients in complex and challenging transactions and antitrust litigation for nearly 20 years. Peter has tried six merger litigations to final decisions, both for and against the government, including groundbreaking cases on behalf of the Federal Trade Commission. In addition to representing clients on mergers and acquisitions before the FTC, Department of Justice, and other antitrust regulators, Peter leads high stakes antitrust litigation for clients in federal court. Clients trust Peter’s strategic approach to both transactions and disputes, value his clear judgment, and depend on his credibility both in court and before the antitrust agencies.
Prior to returning to private practice, Peter was Senior Trial Counsel in the FTC’s Bureau of Competition. In that role, Peter co-led the FTC's 18-day trial and victory in FTC et al. v. St. Luke's Health System, Inc. et al., the FTC’s first successfully litigated merger challenge of a hospital system’s acquisition of a physician group.
While in the FTC’s Mergers IV Division, he was a key trial team member in the FTC's successful merger challenges in FTC v. Phoebe Putney Health System and FTC v. OSF Health System. While at the FTC, Peter received the Janet D. Steiger Award three times for his contributions to key litigations.
O'Melveny & Myers LLP
Partner Stephen McIntyre
Stephen McIntyre is a versatile antitrust lawyer who represents clients in civil and criminal investigations, government enforcement actions, and high-stakes private litigation. Stephen brings skill, insight, and practicality to each matter—be it a nationwide class action, a suit against a client’s chief competitor, or an inquiry from a federal or state antitrust enforcer.
Stephen has secured victories for clients in the pharmaceutical, technology, and entertainment industries, among others.
His recent successes include a Ninth Circuit victory affirming the dismissal of antitrust conspiracy claims against manufacturers of dynamic random access memory (DRAM) chips; a sweeping summary judgment win on behalf of ExxonMobil in an antitrust conspiracy case in which plaintiffs sought tens of billions of dollars in damages; the complete dismissal of monopolization and “reverse-payment” claims in In re Humira, an antitrust case involving the world’s highest-selling biologic drug; and an across-the-board summary judgment win in In re Optical Disk Drives, a consumer class action in which plaintiffs sought billions in alleged damages from major electronics companies.
Firm Profile
O’Melveny’s clients shape markets, set precedents, and break boundaries. They are stalwarts and innovators, the names you trust and the next big thing. And for more than 130 years, O’Melveny has helped our clients—businesses and professionals, families and individuals—succeed.
O'Melveny is an international law firm with 800 lawyers of diverse backgrounds, complementary areas of expertise, and a team-oriented ethos. Serving our clients' needs and our ability to add value are paramount. Our corporate lawyers work creatively with clients to help them capitalize on market opportunities and achieve their strategic objectives. Our litigators help clients prevail at all stages of civil and criminal litigation, winning in discovery, on summary judgment, at trial, and on appeal. Whether we’re connecting clients to new business opportunities, collaborating on strategies to push through their obstacles, or trading ideas for maximizing value, our clients’ business objectives are what set our agenda.
Download materials / contact us
You can download or contact us from here.
Please select a category, enter the required items, and press the send button.
